echemi logo
Product
  • Product
  • Supplier
  • Inquiry
    Home > Medical News > Medical World News > Step pharmaceutical benzodiacycline chloride tablets obtained a drug registration certificate

    Step pharmaceutical benzodiacycline chloride tablets obtained a drug registration certificate

    • Last Update: 2021-01-18
    • Source: Internet
    • Author: User
    Search more information of high quality chemicals, good prices and reliable suppliers, visit www.echemi.com
    On November 20, Step Pharmaceuticals announced that Shaanxi Step Gao, a wholly-owned subsidiary, had recently received a "Drug Registration Certificate" for benzodiacycline chloride tablets approved by the State Drug Administration.
    examination and approval shows that, in accordance with the Drug Administration Law of the People's Republic of China and the relevant provisions, after examination, the product meets the relevant requirements of drug registration, approves registration, and issues a drug registration certificate.
    quality standards, instructions, packaging labels and production processes attached to the implementation.
    is mainly suitable for hypertension, chronic stable angina, vasoconvulsive angina and coronary heart disease confirmed by angiocardiosis.
    the original research manufacturer is Pfizer Pharmaceutical Co., Ltd.
    according to Minenet data, the sales of sample hospitals from 2016 to 2019 were: 4.03 billion yuan, 4.352 billion yuan, 4.791 billion yuan and 4.762 billion yuan.
    date of this announcement, Step Pharmaceuticals has invested approximately RMB8.94 million in research and development on ammonia chloride tablets.
    This article is an English version of an article which is originally in the Chinese language on echemi.com and is provided for information purposes only. This website makes no representation or warranty of any kind, either expressed or implied, as to the accuracy, completeness ownership or reliability of the article or any translations thereof. If you have any concerns or complaints relating to the article, please send an email, providing a detailed description of the concern or complaint, to service@echemi.com. A staff member will contact you within 5 working days. Once verified, infringing content will be removed immediately.

    Contact Us

    The source of this page with content of products and services is from Internet, which doesn't represent ECHEMI's opinion. If you have any queries, please write to service@echemi.com. It will be replied within 5 days.

    Moreover, if you find any instances of plagiarism from the page, please send email to service@echemi.com with relevant evidence.